04:04 AM EDT, 07/09/2025 (MT Newswires) -- Cogent Biosciences ( COGT ) said late Tuesday it has priced an underwritten public offering of about 22.2 million common shares at $9 per share for expected gross proceeds of about $200 million.

Underwriters have been granted a 30-day option to purchase up to about 3.3 million additional shares.

Net proceeds from the offering, which is set to close around July 10, will be used to fund development, regulatory and commercial activities, as well as for working capital and general corporate purposes.